Cargando…

Polo-like kinase 4 inhibitor CFI-400945 inhibits carotid arterial neointima formation but increases atherosclerosis

Neointima lesion and atherosclerosis are proliferative vascular diseases associated with deregulated proliferation of vascular smooth muscle cells (SMCs). CFI-400945 is a novel, highly effective anticancer drug that inhibits polo-like kinase 4 (PLK4) and targets mitosis. In this study, we aim to inv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jiaxing, Belke, Darrell, Gui, Yu, Chen, Yong-Xiang, Zhou, Shenghua, Zheng, Xi-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905587/ https://www.ncbi.nlm.nih.gov/pubmed/36750553 http://dx.doi.org/10.1038/s41420-023-01305-4

Ejemplares similares

Activity of the novel polo-like kinase 4 inhibitor CFI-400945 in pancreatic cancer patient-derived xenografts
por: Lohse, Ines, et al.
Publicado: (2016)

Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer
por: Parsyan, Armen, et al.
Publicado: (2021)

Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing’s sarcoma cells
por: Kerschner-Morales, Sophie L., et al.
Publicado: (2020)

Safety and tolerability of CFI-400945, a first-in-class, selective PLK4 inhibitor in advanced solid tumours: a phase 1 dose-escalation trial
por: Veitch, Zachary W., et al.
Publicado: (2019)

Myotubularin‐Related Protein14 Prevents Neointima Formation and Vascular Smooth Muscle Cell Proliferation by Inhibiting Polo‐Like Kinase1
por: Kong, Ling‐Yao, et al.
Publicado: (2022)

Mobilization of Regulatory T Cells in Response to Carotid Injury Does Not Influence Subsequent Neointima Formation
por: Saxena, Amit, et al.
Publicado: (2012)

Mitotic spindle formation in the absence of Polo kinase
por: Kim, Juyoung, et al.
Publicado: (2022)

Distinct Differences on Neointima Formation in Immunodeficient and Humanized Mice after Carotid or Femoral Arterial Injury
por: Moser, Jill, et al.
Publicado: (2016)

Pathological Role of Phosphoglycerate Kinase 1 in Balloon Angioplasty-Induced Neointima Formation
por: Pan, Chun-Hsu, et al.
Publicado: (2021)

Polo-like kinase in trypanosomes: an odd member out of the Polo family
por: Kurasawa, Yasuhiro, et al.
Publicado: (2020)

Effects of tongxinluo on the neointima formation and expression of inflammatory cytokines in rats after carotid artery balloon injury
por: Yao, En-Hui, et al.
Publicado: (2014)

Influence of valsartan-eluting stent on neointima formation
por: Guihua, Li, et al.
Publicado: (2010)

Uremia does not affect neointima formation in mice
por: Aarup, Annemarie, et al.
Publicado: (2017)

The Content Validity of the Cultural Formulation Interview (CFI)
por: Shariati, Behnam, et al.
Publicado: (2018)

Putting a bit into the polo-box domain of polo-like kinase 1
por: Park, Jung-Eun, et al.
Publicado: (2015)

The balance of Polo-like kinase 1 in tumorigenesis
por: Lu, Lin-Yu, et al.
Publicado: (2009)

The CINs of Polo-Like Kinase 1 in Cancer
por: Cunningham, Chelsea E., et al.
Publicado: (2020)

A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model
por: Huang, Chen, et al.
Publicado: (2017)

Down‐regulation of Suv39h1 attenuates neointima formation after carotid artery injury in diabetic rats
por: Zhang, Jing, et al.
Publicado: (2019)

A proteomics analysis of neointima formation on decellularized vascular grafts reveals regenerative alterations in protein signature running head: Proteomics analysis of neointima formation
por: Chen, Chunyang, et al.
Publicado: (2022)

3,3′Diindolylmethane Suppresses Vascular Smooth Muscle Cell Phenotypic Modulation and Inhibits Neointima Formation after Carotid Injury
por: Guan, Hongjing, et al.
Publicado: (2012)

DN200434 Inhibits Vascular Smooth Muscle Cell Proliferation and Prevents Neointima Formation in Mice after Carotid Artery Ligation
por: Kumar, Sudeep, et al.
Publicado: (2022)

Suppression of neointima formation by targeting β-catenin/TCF pathway
por: Williams, Helen, et al.
Publicado: (2016)

Oral Charcoal Adsorbents Attenuate Neointima Formation of Arteriovenous Fistulas
por: Shih, Yu-Chung, et al.
Publicado: (2020)

Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1
por: Yun, Sang-Moon, et al.
Publicado: (2009)

A selective inhibitor of the Polo-box domain of Polo-like kinase 1 identified by virtual screening
por: Abdelfatah, Sara, et al.
Publicado: (2018)

Polo-like kinase-1 in DNA damage response
por: Hyun, Sun-Yi, et al.
Publicado: (2014)

Polo-like kinase 1 as target for cancer therapy
por: Weiß, Lily, et al.
Publicado: (2012)

Playing POLO-like kinase in NRAS mutant melanoma
por: Chen, Hsin-Yi, et al.
Publicado: (2015)

Role for polo-like kinase 4 in mediation of cytokinesis
por: Press, Michael F., et al.
Publicado: (2019)

Polo-Like Kinase 2: From Principle to Practice
por: Zhang, Chuanyong, et al.
Publicado: (2022)

Polo-like kinase 1 promotes pulmonary hypertension
por: Chen, Rongrong, et al.
Publicado: (2023)

PDZK1 Prevents Neointima Formation via Suppression of Breakpoint Cluster Region Kinase in Vascular Smooth Muscle
por: Lee, Wan Ru, et al.
Publicado: (2015)

WD Repeat Domain 1 Deficiency Inhibits Neointima Formation in Mice Carotid Artery by Modulation of Smooth Muscle Cell Migration and Proliferation
por: Hu, JiSheng, et al.
Publicado: (2020)

Exploring the Binding Nature of Pyrrolidine Pocket-Dependent Interactions in the Polo-Box Domain of Polo-Like Kinase 1
por: Murugan, Ravichandran N., et al.
Publicado: (2013)

Identification of a novel Polo-like kinase 1 inhibitor that specifically blocks the functions of Polo-Box domain
por: Chen, Yunyu, et al.
Publicado: (2016)

A Novel Resveratrol Analog Upregulates SIRT1 Expression and Ameliorates Neointima Formation
por: Yuan, Baohui, et al.
Publicado: (2021)

Drosophila Polo Kinase Is Required for Cytokinesis
por: Carmena, Mar, et al.
Publicado: (1998)

Polo kinase: the choreographer of the mitotic stage?
Publicado: (1996)

Regulation of the polo kinase during cytokinesis
por: Kachaner, David
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o10bj9qq5jghpvpulluqggbmpa